Login
From:
jamanetwork.com
(Uncensored)
subscribe
Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss | Gastroenterology | JAMA | JAMA Network
https://jamanetwork.com/journals/jama/fullarticle/2810542
links
backlinks
This database study examines the association between glucagon-like peptide 1 agonists (eg, semaglutide, liraglutide) used for weight loss and reports of gastrointestinal adverse events.
Roast topics
Find topics
Find it!
